Platinum-resistant recurrent epithelial ovarian cancer carries a bleak prognosis, with single-agent chemotherapy yielding ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with ...

Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) (“Nevada King” or the “Company”) is pleased to provide a summary of its key ...

VANCOUVER, BC, Dec. 29, 2025 /PRNewswire/ - Nevada King Gold Corp. (TSXV: NKG) (OTCQB: NKGFF) ("Nevada King" or the "Company") is pleased to provide a summary of its ...

EMA provided overall agreement with the proposed Phase 3 clinical trial of VCN-01 in combination with gemcitabine/nab-paclitaxel for the first-line treatment of metastatic PDAC, including sample size ...

Detailed price information for Ovid Therapeutics Inc (OVID-Q) from The Globe and Mail including charting and trades.

Theriva Biologics (TOVX) announced the receipt of Scientific Advice from the Committee for Medicinal Products for Human Use ...

The FLAMINGO-01 DSMB met twice in 2025, most recently in December 2025, and recommended to continue the study as is without modification. The Steering Committee also met at SABCS 2025 and discussed ...

Western Yilgarn is moving into the field on two fronts, kicking off ground exploration at the Ida Holmes Junction project ...

A highly fragmented market with immense growth potential the cold chain market in Australia is highly competitive, with numerous players offering cold storage, transportation, and logistics services.